Welcome to LookChem.com Sign In|Join Free
  • or
Spiro[benzofuran-2(3H),4'-piperidine], 1'-(phenylMethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

71916-71-7

Post Buying Request

71916-71-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

71916-71-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 71916-71-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,9,1 and 6 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 71916-71:
(7*7)+(6*1)+(5*9)+(4*1)+(3*6)+(2*7)+(1*1)=137
137 % 10 = 7
So 71916-71-7 is a valid CAS Registry Number.

71916-71-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1'-benzylspiro[3H-1-benzofuran-2,4'-piperidine]

1.2 Other means of identification

Product number -
Other names 1'-benzyl-2,3-dihydrospiro<benzofuran-2,4'-piperidine>

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:71916-71-7 SDS

71916-71-7Downstream Products

71916-71-7Relevant academic research and scientific papers

SPIROPIPERIDINE DERIVATIVES

-

, (2018/07/05)

Described herein are spiropiperidine compounds according to Formula I that have demonstrated activity as fatty acid synthase inhibitors. Also described herein are pharmaceutical compositions containing the described spiropiperidine compounds, and methods

MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS

-

, (2015/05/26)

The present invention relates to compounds compound according to Formula (III); and pharmaceutically acceptable salts, hydrates and solvates thereof. These compounds have D2receptor antagonist/(partial) agonist effects and H3antagonistic effects, pharmaceutical compositions thereof, and methods of using them for application in the prophylaxis or treatment of CNS disorders.

HISTAMINE H3 INVERSE AGONISTS AND ANTAGONISTS AND METHODS OF USE THEREOF

-

Page/Page column 128, (2010/12/29)

Provided herein are spiro-cyclic compounds, methods of synthesis, and methods of use thereof. The compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, including, e.g., neurological disorders and metab

Synthesis of 2,3-Dihydrospiro and 2,3-dihydrospiro

Effland, Richard C.,Gardner, Beth Ann,Strupczewski, Joseph

, p. 811 - 814 (2007/10/02)

The synthesis of 2,3-dihydrospiro 3 and 2,3-dihydrospiro 6 is described.The synthesis was achieved by a Grignard reaction of a 2-fluorobenzylhalide with an appropriate cycloazaalkyl ketone to yield

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 71916-71-7